Concepedia

Results of the randomized, placebo-controlled phase I/IIB trial of CV9104, an mRNA based cancer immunotherapy, in patients with metastatic castration-resistant prostate cancer (mCRPC)

Arnulf Stenzl, S. Feyerabend, Isabel Syndikus, Tomasz Sarosiek, Hubert Kübler, Axel Heidenreich, Richard Cathomas, Carsten Grüllich, Yohann Loriot, S.L. Perez Gracia,

Annals of Oncology · 2017 · 68 citations · 0 references

Concepts

MedicineImmunologyOncologyCancer ImmunologyImmunotherapyTumor ImmunologyCancer ImmunotherapyImmunotherapy For Genitourinary CancersImmunotherapy For Urologic CancersMetastatic Disease TreatmentProstate CancerTargeted TherapyCancer Immunotherapy ResistanceCastration-resistant Prostate Cancer TherapyMetastatic Castration-resistant Prostate CancerPlacebo-controlled Efficacy AssessmentProstate Cancer ImmunotherapyProstate-specific Antigen - Targeted TherapyRna Vaccine Immunotherapy